Your browser doesn't support javascript.
loading
A single-centre analysis of post-colonoscopy colorectal cancer.
Aerts, R; Severi, C; Van Roey, G; Harlet, R; T'Syen, M; Claessens, C; Van Gool, S; Croonen, C; Janssens, J.
Afiliação
  • Aerts R; Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Severi C; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
  • Van Roey G; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium.
  • Harlet R; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium.
  • T'Syen M; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium.
  • Claessens C; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium.
  • Van Gool S; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium.
  • Croonen C; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium.
  • Janssens J; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium.
Acta Gastroenterol Belg ; 84(3): 401-405, 2021.
Article em En | MEDLINE | ID: mdl-34599562
ABSTRACT
PATIENTS AND

METHODS:

A prospective registration of patients with colorectal cancer and a colonoscopy within the last 10 years. We tried to classify these post-colonoscopy colorectal cancers (PCCRCs) by most reasonable explanation and into subcategories suggested by the World Endoscopy Organization (WEO) and calculated the unadjusted PCCRC rate.

RESULTS:

47 PCCRCs were identified. The average age at diagnosis of PCCRC was 73 years. PCCRCs were more located in the right colon with a higher percentage of MSI-positive and B-RAF mutated tumours. The average period between index colonoscopy and diagnosis of PCCRC was 4.2 years. Sixty-eight % of all PCCRCs could be explained by procedural factors. The mean PCCRC-3y of our department was 2.46%.

CONCLUSIONS:

The data of our centre are in line with the data of the literature from which can be concluded that most postcolonoscopy colorectal cancers are preventable. The PCCRC-3y is an important quality measure for screening colonoscopy. Ideally all centres involved in the population screening should measure the PCCRC-3 y annually, with cooperation of the cancer registry and reimbursement data provided by the Intermutualistic Agency (IMA).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Idioma: En Ano de publicação: 2021 Tipo de documento: Article